Am J Perinatol 2024; 41(01): 098-105
DOI: 10.1055/s-0041-1740154
Original Article

The Hassan Neonatal Morbidity Composite Scale and Neonatal Length of Stay—A Validation Study

Avinash S. Patil
1   Department of Obstetrics and Gynecology, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona
2   Valley Perinatal Services, Phoenix, Arizona
,
Chad A. Grotegut
3   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Wake Forest University, Winston-Salem, North Carolina
,
P. Brian Smith
4   Division of Neonatology, Department of Pediatrics, Duke University, Durham, North Carolina
5   Duke Clinical Research Institute, Durham, North Carolina
,
6   MEDNAX Center for Research, Education, Quality, and Safety, Sunrise, Florida
,
Rachel G. Greenberg
4   Division of Neonatology, Department of Pediatrics, Duke University, Durham, North Carolina
5   Duke Clinical Research Institute, Durham, North Carolina
› Author Affiliations
Funding None.

Abstract

Objective Obstetric studies often report neonatal morbidity as a composite score. Composite scores can simplify data analysis when multiple outcomes of interest are present and allows researchers to conduct smaller, more manageable trials. The Hassan scale is a neonatal morbidity composite scale that assigns high scores to infants with multiple morbidities and low scores to infants without or with single morbidities. The objective of this study was to validate the association between scores on the Hassan scale and neonatal intensive care unit (NICU) length of stay

Study Design We conducted a cohort study of all infants born between 22 and 366/7 weeks' gestation and cared for within 419 neonatal units in the Pediatrix Medical Group between 1997 and 2018. Each infant was assigned a Hassan's score based on the number of neonatal morbidity events that occurred during the delivery hospitalization. The association between Hassan's scores and neonatal length of stay was evaluated using linear regression. Multivariable models were constructed to determine if the Hassan score was independently associated with neonatal length of stay.

Results There were 760,037 infants included. The median (interquartile range [IQR]) gestational age of delivery was 34 (31, 35) weeks and the median (IQR) birth weight at delivery was 2,000 (1,503, 2,430) g. The median length of stay for infants discharged home was 17 (10–33) days. A Hassan's score was able to be assigned to 699,206 (92%) patients. Neonatal morbidities included in the Hassan scale were more common among infants born earlier in gestation. On adjusted analysis, the Hassan scale was found to be independently associated with neonatal length of stay (p < 0.001, coefficient = 10.4 days [95% confidence interval (CI): 10.3, 10.4 days]) with higher scores associated with longer lengths of stay.

Conclusion The Hassan scale, more than a binary composite score, is able to differentiate preterm infants with prolonged hospitalizations from those with short hospitalizations.

Key Points

  • The Hassan scale is an independent predictor of neonatal length of stay.

  • Classification of infants based on number of morbidities correlates with neonatal length of stay.

  • The Hassan scale provided better discrimination than binary composite morbidity scores.

  • The Hassan scale may be an economic predictor of health-related costs.

Supplementary Material



Publication History

Received: 20 July 2021

Accepted: 03 October 2021

Article published online:
02 December 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, Willan AR. Term Breech Trial Collaborative Group. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Lancet 2000; 356 (9239): 1375-1383
  • 2 Guinn DA, Atkinson MW, Sullivan L. et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA 2001; 286 (13) 1581-1587
  • 3 Crowther CA, Hiller JE, Doyle LW, Haslam RR. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003; 290 (20) 2669-2676
  • 4 Rouse DJ, Hirtz DG, Thom E. et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (09) 895-905
  • 5 Gyamfi-Bannerman C, Thom EA, Blackwell SC. et al; NICHD Maternal–Fetal Medicine Units Network. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med 2016; 374 (14) 1311-1320
  • 6 Grobman WA, Rice MM, Reddy UM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med 2018; 379 (06) 513-523
  • 7 Hassan SS, Romero R, Vidyadhari D. et al; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38 (01) 18-31
  • 8 Patil AS, Grotegut CA, Gaikwad NW, Dowden SD, Haas DM. Prediction of neonatal morbidity and very preterm delivery using maternal steroid biomarkers in early gestation. PLoS One 2021; 16 (01) e0243585
  • 9 Spitzer AR, Ellsbury DL, Handler D, Clark RH. The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system–tools for “meaningful use” in continuous quality improvement. Clin Perinatol 2010; 37 (01) 49-70
  • 10 Trembath A, Hornik CP, Clark R, Smith PB, Daniels J, Laughon M. Best Pharmaceuticals for Children Act—Pediatric Trials Network. Comparative effectiveness of surfactant preparations in premature infants. J Pediatr 2013; 163 (04) 955-60.e1
  • 11 Rouse DJ, Caritis SN, Peaceman AM. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007; 357 (05) 454-461
  • 12 Phibbs CS, Schmitt SK. Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants. Early Hum Dev 2006; 82 (02) 85-95
  • 13 Russell RB, Green NS, Steiner CA. et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 2007; 120 (01) e1-e9
  • 14 Schmitt SK, Sneed L, Phibbs CS. Costs of newborn care in California: a population-based study. Pediatrics 2006; 117 (01) 154-160
  • 15 Singer LT, Salvator A, Guo S, Collin M, Lilien L, Baley J. Maternal psychological distress and parenting stress after the birth of a very low-birth-weight infant. JAMA 1999; 281 (09) 799-805
  • 16 Cherry AS, Mignogna MR, Roddenberry Vaz A. et al. The contribution of maternal psychological functioning to infant length of stay in the neonatal intensive care unit. Int J Womens Health 2016; 8: 233-242
  • 17 Beam AL, Fried I, Palmer N. et al. Estimates of healthcare spending for preterm and low-birthweight infants in a commercially insured population: 2008-2016. J Perinatol 2020; 40 (07) 1091-1099
  • 18 Manuck TA, Henry E, Gibson J. et al. Pregnancy outcomes in a recurrent preterm birth prevention clinic. Am J Obstet Gynecol 2011; 204 (04) 320.e2-326
  • 19 Markham KB, Walker H, Lynch CD, Iams JD. Preterm birth rates in a prematurity prevention clinic after adoption of progestin prophylaxis. Obstet Gynecol 2014; 123 (01) 34-39
  • 20 World Health Organization. . Preterm birth. Accessed October 16, 2020 at: https://www.who.int/news-room/fact-sheets/detail/preterm-birth
  • 21 Lain SJ, Algert CS, Nassar N, Bowen JR, Roberts CL. Incidence of severe adverse neonatal outcomes: use of a composite indicator in a population cohort. Matern Child Health J 2012; 16 (03) 600-608
  • 22 Verma A, Okun NB, Maguire TO, Mitchell BF. Morbidity assessment index for newborns: a composite tool for measuring newborn health. Am J Obstet Gynecol 1999; 181 (03) 701-708
  • 23 World Health Organization. Preterm Birth Fact Sheets. In; 2018. Accessed October 16, 2020 at: https://www.who.int/news-room/fact-sheets/detail/preterm-birth